You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Long-term benefit of rituximab in MuSK autoantibody myasthenia gravis patients

https://doi.org/10.1136/jnnp-2012-303664

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • BK and RJN contributed equally.

    • Contributors BK: Data collection, analysis, drafting and revision of manuscript. KRR: Data collection, analysis and revision of manuscript. DBD, JBR, KCO: Data analysis and revision of manuscript. JMG: Study conception and revision of manuscript. RJN: Study conception, data collection, analysis, drafting and revision of manuscript.

    • Competing interests None.

    • Ethics approval Approval to complete a retrospective chart review was provided by our institutional review board, Yale Human Investigation Committee.

    • Provenance and peer review Not commissioned; externally peer reviewed.